These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22458996)

  • 21. Longitudinal trends, hemodynamic profiles, and prognostic value of abnormal liver function tests in patients with acute decompensated heart failure: an analysis of the ESCAPE trial.
    Scholfield M; Schabath MB; Guglin M
    J Card Fail; 2014 Jul; 20(7):476-84. PubMed ID: 24845963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic Value of Hepatorenal Function By Modified Model for End-stage Liver Disease (MELD) Score in Patients Undergoing Tricuspid Annuloplasty.
    Chen Y; Liu YX; Seto WK; Wu MZ; Yu YJ; Lam YM; Au WK; Chan D; Sit KY; Ho LM; Tse HF; Yiu KH
    J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 30006492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MELD at POD 1 as a predictor of outcome in liver allografts with peak AST >5000 U/l.
    Hoyer DP; Sotiropoulos GC; Saner FH; Treckmann JW; Paul A; Mathé Z
    Transpl Int; 2014 Dec; 27(12):1285-93. PubMed ID: 25082387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive Value of Hepatic and Renal Dysfunction Based on the Models for End-Stage Liver Disease in Patients With Heart Failure Evaluated for Heart Transplant.
    Szyguła-Jurkiewicz B; Nadziakiewicz P; Zakliczynski M; Szczurek W; Chraponski J; Zembala M; Gasior M
    Transplant Proc; 2016 Jun; 48(5):1756-60. PubMed ID: 27496486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Usefulness of Cardiac MetaIodobenzylguanidine Imaging to Improve Prognostic Power of the Model for End-Stage Liver Disease Scoring System in Patients With Mild-to-Moderate Chronic Heart Failure.
    Hakui H; Yamada T; Tamaki S; Morita T; Furukawa Y; Iwasaki Y; Kawasaki M; Kikuchi A; Kondo T; Ishimi M; Sato Y; Seo M; Ozaki T; Ikeda I; Fukuhara E; Sakata Y; Fukunami M
    Am J Cardiol; 2016 Jun; 117(12):1947-52. PubMed ID: 27237625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of the modified model for end-stage liver disease (MELD) score including albumin in acute heart failure.
    Liao S; Lu X; Cheang I; Zhu X; Yin T; Yao W; Zhang H; Li X
    BMC Cardiovasc Disord; 2021 Mar; 21(1):128. PubMed ID: 33750318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heart Transplant and Hepato-Renal Dysfunction: The Model of End-Stage Liver Disease Excluding International Normalized Ratio as a Predictor of Postoperative Outcomes.
    Loforte A; Fiorentino M; Gliozzi G; Mariani C; Folesani G; Suarez SM; Russo A; Masetti M; Potena L; Pacini D
    Transplant Proc; 2019 Nov; 51(9):2962-2966. PubMed ID: 31607616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Scores for Child-Pugh Criteria and Standard and Modified Models for End-Stage Liver Disease to Assess Cardiac Hepatopathy in Heart Transplant Recipients.
    Naghashzadeh F; Noorali S; Hosseini-Baharanchi FS; Shafaghi S; Sharif-Kashani B; Ahmadi ZH; Keshmiri MS
    Exp Clin Transplant; 2021 Sep; 19(9):963-969. PubMed ID: 34545779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The aspartate transaminase/alanine transaminase (DeRitis) ratio predicts mid-term mortality and renal and respiratory dysfunction after left ventricular assist device implantation.
    Pilarczyk K; Carstens H; Heckmann J; Canbay A; Koch A; Pizanis N; Jakob H; Kamler M
    Eur J Cardiothorac Surg; 2017 Oct; 52(4):781-788. PubMed ID: 29156019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Model for end-stage liver disease excluding international normalized ratio (MELD-XI) score predicts heart transplant outcomes: Evidence from the registry of the United Network for Organ Sharing.
    Deo SV; Al-Kindi SG; Altarabsheh SE; Hang D; Kumar S; Ginwalla MB; ElAmm CA; Sareyyupoglu B; Medalion B; Oliveira GH; Park SJ
    J Heart Lung Transplant; 2016 Feb; 35(2):222-7. PubMed ID: 26527533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver function tests in patients with acute heart failure and associated outcomes: insights from ASCEND-HF.
    Samsky MD; Dunning A; DeVore AD; Schulte PJ; Starling RC; Tang WH; Armstrong PW; Ezekowitz JA; Butler J; McMurray JJ; Teerlink JR; Voors AA; Metra M; Mentz RJ; O'Connor CM; Patel CB; Hernandez AF
    Eur J Heart Fail; 2016 Apr; 18(4):424-32. PubMed ID: 26707029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modified model for end-stage liver disease improves short-term prognosis of hepatitis B virus-related acute-on-chronic liver failure.
    Chen W; You J; Chen J; Zheng Q; Jiang JJ; Zhu YY
    World J Gastroenterol; 2017 Oct; 23(40):7303-7309. PubMed ID: 29142477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive value of the model for end-stage liver disease score in patients undergoing left ventricular assist device implantation.
    Deo SV; Daly RC; Altarabsheh SE; Hasin T; Zhao Y; Shah IK; Stulak JM; Boilson BA; Schirger JA; Joyce LD; Park SJ
    ASAIO J; 2013; 59(1):57-62. PubMed ID: 23263341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. THE USE OF MELD SCORE (MODEL FOR END-STAGE LIVER DISEASE) AND DERIVATIVES IN CARDIAC TRANSPLANTATION.
    Moraes ACO; Fonseca-Neto OCLD
    Arq Bras Cir Dig; 2018; 31(2):e1370. PubMed ID: 29972398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Value of pretransplant albumin-bilirubin score in predicting outcomes after liver transplantation.
    Ma T; Li QS; Wang Y; Wang B; Wu Z; Lv Y; Wu RQ
    World J Gastroenterol; 2019 Apr; 25(15):1879-1889. PubMed ID: 31057301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utility of post-liver transplantation MELD and delta MELD in predicting early and late mortality.
    Zakareya T; Abbasy M; Abdel-Razek W; Elsiesy H; Abal Khail F; Al Sebayel M; Waked I
    Eur J Gastroenterol Hepatol; 2017 Dec; 29(12):1424-1427. PubMed ID: 28957872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Limitations of the MELD score in predicting mortality or need for removal from waiting list in patients awaiting liver transplantation.
    Gotthardt D; Weiss KH; Baumgärtner M; Zahn A; Stremmel W; Schmidt J; Bruckner T; Sauer P
    BMC Gastroenterol; 2009 Sep; 9():72. PubMed ID: 19778459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Predictive value of pediatrics end-stage liver disease or model for end-stage liver disease score in the prognosis of pediatric acute liver failure treated with artificial liver support system].
    Jinhao T; Weiming C; Jing H; Jun H; Jian M; Peng S; Zhujin L; Guoping L; Yimin Z
    Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):280-4. PubMed ID: 26182503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preoperative hepatic dysfunction could predict postoperative mortality and morbidity in patients undergoing cardiac surgery: Utilization of the MELD scoring system.
    Murata M; Kato TS; Kuwaki K; Yamamoto T; Dohi S; Amano A
    Int J Cardiol; 2016 Jan; 203():682-9. PubMed ID: 26583843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormal liver function tests in acute heart failure: relationship with clinical characteristics and outcome in the PROTECT study.
    Biegus J; Hillege HL; Postmus D; Valente MA; Bloomfield DM; Cleland JG; Cotter G; Davison BA; Dittrich HC; Fiuzat M; Givertz MM; Massie BM; Metra M; Teerlink JR; Voors AA; O'Connor CM; Ponikowski P
    Eur J Heart Fail; 2016 Jul; 18(7):830-9. PubMed ID: 27170455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.